LHS.CN - Liberty Health Sciences Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 5203.72M
Enterprise Value 3186.74M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)28.75
Price/Book (mrq)1.79
Enterprise Value/Revenue 326.35
Enterprise Value/EBITDA 6-13.02

Trading Information

Stock Price History

Beta (3Y Monthly) 5.10
52-Week Change 3-39.80%
S&P500 52-Week Change 37.14%
52 Week High 31.6300
52 Week Low 30.5500
50-Day Moving Average 30.6961
200-Day Moving Average 30.9023

Share Statistics

Avg Vol (3 month) 3662.06k
Avg Vol (10 day) 3594.31k
Shares Outstanding 5345.29M
Float 279.2M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (May 15, 2019) 42.63M
Short Ratio (May 15, 2019) 43.89
Short % of Float (May 15, 2019) 4N/A
Short % of Shares Outstanding (May 15, 2019) 40.77%
Shares Short (prior month Apr 15, 2019) 43.56M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 23/1
Last Split Date 3Jul 26, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Feb 28, 2018
Most Recent Quarter (mrq)Nov 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-244.95%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)7.09M
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)2,517.10%
Gross Profit (ttm)1.43M
EBITDA -14.34M
Net Income Avi to Common (ttm)-27.71M
Diluted EPS (ttm)-0.0900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)19.16M
Total Cash Per Share (mrq)0.06
Total Debt (mrq)10.69M
Total Debt/Equity (mrq)9.45
Current Ratio (mrq)4.38
Book Value Per Share (mrq)0.33

Cash Flow Statement

Operating Cash Flow (ttm)-13.78M
Levered Free Cash Flow (ttm)N/A